EFFICACY AND SAFETY OF OBINUTUZUMAB + LENALIDOMIDE + ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL.
Saved in:
| Title: | EFFICACY AND SAFETY OF OBINUTUZUMAB + LENALIDOMIDE + ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 1B/2 TRIAL. |
|---|---|
| Authors: | Morschhauser, F., Ghosh, N., Lossos, I., Palomba, M.L., Mehta, A., Casasnovas, O., Stevens, D., Chitra, S., Knapp, A., Nielsen, T., Oestergaard, M., Wenger, M., Salles, G. |
| Source: | Hematological oncology Jun2019 Supplement S2; Vol. 37. |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 0278-0232 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-1069 |
|---|---|
| DOI: | 10.1002/hon.74_2629 |
